Opinion: 5 most widely read First Opinions of 2019
It’s been a banner year for First Opinion. We published nearly 500 essays written by more than 600 authors from industry, academia, government, and private life in the United States and beyond. They took on the mundane, like the implications of the Elijah E. Cummings Lower Drug Costs Now Act (aka ), and the to highlight when drugs go off patent.
